Effect of Vericiguat on Acute Coronary Syndrome( ACS）Patients With Ejection Fraction <45%

Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)

NCT05714085 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

A Study of Real-world Events of Vericiguat in Patients With Chronic Kidney Disease and Heart Failure

NCT07047547 ·Status: RECRUITING ·Phase: NA

An Observational Study to Learn More About Vericiguat Treatment Patterns and Its Safety in People With Chronic Heart Failure With Reduced Ejection Fraction in Routine Medical Care in the United States

NCT06363110 ·Status: COMPLETED

An Observational Study to Learn More About How Safe Vericiguat is and How Well it Works in Indian People With Chronic Heart Failure With Reduced Ejection Fraction and Worsening Chronic Heart Failure Under Real World Conditions

NCT06632483 ·Status: ACTIVE_NOT_RECRUITING

A Study to Learn How Well the Drug Vericiguat Works and How Safe it is Under Real World Conditions in Indian Participants After Worsening of a Long-term Heart Condition in Which the Left Side of the Heart Does Not Pump Blood as Well as it Should (Chronic Heart Failure With Reduced Ejection Fraction)

NCT05658458 ·Status: COMPLETED ·Phase: PHASE4

An Observational Study to Learn More About the Real-world Outcomes in Patients With Heart Failure Who Initiate Treatment With Vericiguat in Japan

NCT06697353 ·Status: COMPLETED

A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)

NCT02861534 ·Status: COMPLETED ·Phase: PHASE3

The Effect of Vericiguat on Peripheral Vascular Function, Patient Health Status and Inflammation

NCT05420012 ·Status: COMPLETED ·Phase: PHASE4

Vericiguat Drug-drug Interaction Study With Isosorbite Mononitrate in Stable Coronary Artery Disease Patients

NCT03255512 ·Status: COMPLETED ·Phase: PHASE1

Impact of Vericiguat on Hemodynamics of Heart Failure

NCT05704478 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Patient-reported Outcomes in Vericiguat-treated Patients With HFpEF

NCT03547583 ·Status: COMPLETED ·Phase: PHASE2

PAtient RegisTry Assessing Effectiveness and Safety of HEart Failure treatmeNt With LCZ696 acrOss CaNada

NCT02957409 ·Status: COMPLETED

Effect of Recombinant Human Brain Natriuretic Peptide on Ventricular Remodeling and Cardiac Function in Patients With Acute Anterior Myocardial Infraction Undergoing Percutaneous Coronary Intervention

NCT06463808 ·Status: RECRUITING

Study of Effects of Sacubitril/Valsartan vs. Enalapril on Aortic Stiffness in Patients With Mild to Moderate HF With Reduced Ejection Fraction

NCT02874794 ·Status: COMPLETED ·Phase: PHASE4

Effect of Sacubitril/Valsartan on Reduced Right Ventricular Ejection Fraction in Patients With CTD

NCT04197050 ·Status: UNKNOWN ·Phase: PHASE4

A Safety Study Comparing Natrecor (Nesiritide) Versus Dobutamine Therapy for Worsening Congestive Heart Failure

NCT00270400 ·Status: COMPLETED ·Phase: PHASE3

Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction

NCT02053493 ·Status: COMPLETED ·Phase: PHASE2

Prospective Monitoring of Angiotensin Receptor Neprilysin Inhibitor in Older Adults With Heart Failure and Frailty

NCT04743063 ·Status: UNKNOWN

Sacubitril-Valsartan in Heart Failure With Preserved Ejection Fraction and Secondary Mitral Valve Regurgitation

NCT05991284 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Effects of the Sodium-glucose Cotransporter 2 Inhibitors+Sacubitril/Valsartan Therapy in Patients With HFrEF.

NCT05934071 ·Status: UNKNOWN

The Bio-Clinical Effects of the (Sacubitril-Valsartan) Combination on Patients With Chronic Heart Failure

NCT04688294 ·Status: COMPLETED ·Phase: PHASE4

A Cohort Study to Compare the Hospitalization Between Naive Sacubitril/Valsartan and Naive ACEi/ARBs Heart Failure Patients With Reduced Ejection Fraction Using Secondary US Electronic Health Records Data

NCT05096143 ·Status: COMPLETED

A Study Comparing Blood Flow and Clinical and Safety Effects of the Addition of Natrecor (Nesiritide), Placebo or Intravenous Nitroglycerin to Standard Care for the Treatment of Worsening Congestive Heart Failure.

NCT00270374 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of the Effect of Injectable Neucardin on Cardiac Function and Reversal Ventricular Remodeling in Patients With Chronic Systolic Heart Failure

NCT05949801 ·Status: COMPLETED ·Phase: PHASE3

Six Months Clinical and Echocardiographic Outcome of ARNI LCZ696 Therapy in HFrEF Patients

NCT03816306 ·Status: COMPLETED